{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:28:31Z","timestamp":1793766511601,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Frankfurt","id":[{"id":"https:\/\/ror.org\/03f6n9m15","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>How have the demographics of radiotherapy patients changed between 2015 and 2022? What was the impact of the pandemic, of modified multidisciplinary therapy concepts, and of structural changes on our patient cohort?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed the data of all patients who underwent computed tomography-guided radiotherapy or ultrasound-planned high dose rate prostate brachytherapy at our department between 2015 and 2022. We examined tumor diagnoses in terms of frequency, age of the patients and the distance between patients\u02bc place of residence and our department.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A\u00a0total of 8842 patients underwent radiotherapy at our clinic between 2015 and 2022. The median age at treatment increased from 62\u00a0years in 2015 to 64\u00a0years in 2022. Within the entire cohort, 18% underwent metastasis-directed radiotherapy, 13% had radiotherapy for head and neck tumors, and 12% for breast or prostate cancer. Skin cancer treatments increased in frequency by 79% during study period, while prostate treatments rose by 10%. Overall, 47% of all patients lived within a\u00a010-km radius of our clinic. Patients who received brachytherapy for cervical or endometrial cancer travelled significantly further. During the national epidemic emergency (03\/2020 to 11\/2021), there was no significant change in the long-term average number of patients or the proportion of cancer types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There has been a\u00a0significant increase in radiotherapy treatments for skin cancer, alongside an aging patient population. Although we primarily act as a\u00a0local radiotherapy partner, the increased travel distances for brachytherapy patients underscore the particular responsibility of a\u00a0university radiotherapy department as a\u00a0primary center and key provider of comprehensive cancer care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00066-026-02541-0","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:51:27Z","timestamp":1789127487000},"page":"1146-1156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in radiation oncology between 2015 and 2022: report from a\u00a0German university radio-oncology department"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9042-9729","authenticated-orcid":false,"given":"M.","family":"Diefenhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3627-7370","authenticated-orcid":false,"given":"D.","family":"Imhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Tselis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-2683","authenticated-orcid":false,"given":"D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"11","key":"2541_CR1","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMra1608986","volume":"377","author":"DE Citrin","year":"2017","unstructured":"Citrin DE (2017) Recent Developments in Radiotherapy. N\u00a0Engl J Med 377(11):1065\u20131075. https:\/\/doi.org\/10.1056\/NEJMra1608986","journal-title":"N Engl J Med"},{"issue":"7","key":"2541_CR2","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/1878-0261.12712","volume":"14","author":"V Valentini","year":"2020","unstructured":"Valentini V, Boldrini L, Mariani S, Massaccesi M (2020) Role of radiation oncology in modern multidisciplinary cancer treatment. Mol Oncol 14(7):1431\u20131441. https:\/\/doi.org\/10.1002\/1878-0261.12712","journal-title":"Mol Oncol"},{"key":"2541_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.oraloncology.2018.10.004","volume":"86","author":"MR Bonomi","year":"2018","unstructured":"Bonomi MR, Blakaj A, Blakaj D (2018) Organ preservation for advanced larynx cancer: A\u00a0review of chemotherapy and radiation combination strategies. Oral Oncol 86:301\u2013306. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.10.004","journal-title":"Oral Oncol"},{"issue":"6","key":"2541_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S2468-1253(25)00049-4","volume":"10","author":"C Gani","year":"2025","unstructured":"Gani C, Fokas E, Polat B, Ott OJ, Diefenhardt M, Konigsrainer A, Boke S, Kirschniak A, Bachmann R, Wichmann D, Bitzer M, Clasen S, Grosse U, Hoffmann R, Gotz M, Hofheinz RD, Germer E, Germer CT, Fietkau R, Rodel C et\u00a0al (2025) Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO\/ARO\/AIO-16): an open-label, multicentre, single-arm, phase 2 trial. Lancet Gastroenterol Hepatol 10(6):562\u2013572. https:\/\/doi.org\/10.1016\/S2468-1253(25)00049-4","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"2541_CR5","doi-asserted-by":"publisher","first-page":"e2549685","DOI":"10.1001\/jamanetworkopen.2025.49685","volume":"8","author":"J Willmann","year":"2025","unstructured":"Willmann J, von Wachter C, Zehnder R, Dee EC, Chen H, Hendriks LEL, Remon J, Baker S, Mayinger M, Andratschke N, Shaverdian N, Gomez DR, Ricardi U, Olson R, Sahgal A, De Ruysscher D, Iyengar P, Guckenberger M (2025) Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer: A\u00a0Systematic Review and Meta-Analysis. JAMA Network Open 8(12):e2549685\u2013e2549685. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.49685","journal-title":"JAMA Network Open"},{"key":"2541_CR6","unstructured":"IQVIA (2024) Assessing the clinical trial ecosystem in Europe. https:\/\/www.efpia.eu\/media\/o2gjnmfu\/efpia_ve_iqvia_assessing-the-clinical-trial-ct-ecosystem.pdf"},{"key":"2541_CR7","unstructured":"\u00c4rzteblatt, D. (2023) Krankenhausreform: Standort-konzentration vor allem in Ballungsgebieten. Deutsches \u00c4rzteblatt. https:\/\/www.aerzteblatt.de\/news\/krankenhausreform-standortkonzentration-vor-allem-in-ballungsgebieten-f6499d65-7c3b-441f-a2cc-9f77d46d460d"},{"issue":"15","key":"2541_CR8","doi-asserted-by":"publisher","first-page":"14329","DOI":"10.1007\/s00432-023-05063-9","volume":"149","author":"KK De Santis","year":"2023","unstructured":"De Santis KK, Helmer S, Barnes B, Kraywinkel K, Imhoff M, Muller-Eberstein R, Kirstein M, Quatmann A, Simke J, Stiens L, Christianson L, Zeeb H (2023) Impact of the COVID-19 pandemic on oncological care in Germany: rapid review. J\u00a0Cancer Res Clin Oncol 149(15):14329\u201314340. https:\/\/doi.org\/10.1007\/s00432-023-05063-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"2541_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115234","volume":"217","author":"GF Foppele","year":"2025","unstructured":"Foppele GF, Fiocco M, Ubbels JF, Been LB, de Haan JJ, Schinagl DAX, Bonenkamp H, Desar IME, Scholten AN, van Houdt WJ, Heimans L, Hartgrink HH, Gelderblom H, van Hezewijk M, Haas RLM, Wiltink LM (2025) Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas. Eur J Cancer 217:115234. https:\/\/doi.org\/10.1016\/j.ejca.2025.115234","journal-title":"Eur J Cancer"},{"key":"2541_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111200","volume":"213","author":"JR Gunther","year":"2025","unstructured":"Gunther JR, Yang JC, Hajj C, Ng AK, Brady JL, Cheng S, Levis M, Qi S, George Mikhaeel N, Ricardi U, Illidge TM, Turin A, Knafl M, Specht L, Dabaja BS, Yahalom J, International Lymphoma Radiation Oncology, G (2025) Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A\u00a0COVID-era ILROG collaborative report. Radiother Oncol 213:111200. https:\/\/doi.org\/10.1016\/j.radonc.2025.111200","journal-title":"Radiother Oncol"},{"key":"2541_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2024.100807","volume":"47","author":"AH Eijkelboom","year":"2024","unstructured":"Eijkelboom AH, Stam MR, van den Bongard D, Sattler MGA, Bantema-Joppe EJ, Siesling S, van Maaren MC (2024) Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands. Clin Transl Radiat Oncol 47:100807. https:\/\/doi.org\/10.1016\/j.ctro.2024.100807","journal-title":"Clin Transl Radiat Oncol"},{"issue":"6","key":"2541_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00066-022-01914-5","volume":"198","author":"K Sieker","year":"2022","unstructured":"Sieker K, Fleischmann M, Trommel M, Ramm U, Licher J, Bug G, Martin H, Serve H, Rodel C, Balermpas P (2022) Twenty years of experience of a\u00a0tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies. Strahlenther Onkol 198(6):547\u2013557. https:\/\/doi.org\/10.1007\/s00066-022-01914-5","journal-title":"Strahlenther Onkol"},{"issue":"6-7","key":"2541_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.canrad.2019.07.156","volume":"23","author":"C Hennequin","year":"2019","unstructured":"Hennequin C, Guillerm S, Quero L (2019) Rationale for hypofractionation. Cancer Radiother 23(6-7):500\u2013502. https:\/\/doi.org\/10.1016\/j.canrad.2019.07.156","journal-title":"Cancer Radiother"},{"key":"2541_CR14","unstructured":"Koch-Institut R (2025) Krebs in Deutschland f\u00fcr 2021 \u2013 2023 (GEMEINSAME PUBLIKATION DES ZENTRUMS F\u00dcR KREBSREGISTERDATEN UND DES DEUTSCHEN KREBSREGISTER E.V, Issue. https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/krebs_in_deutschland_2025.pdf?__blob=publicationFile"},{"issue":"1","key":"2541_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","volume":"26","author":"H Sung","year":"2025","unstructured":"Sung H, Siegel RL, Laversanne M, Jiang C, Morgan E, Zahwe M, Cao Y, Bray F, Jemal A (2025) Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol 26(1):51\u201363. https:\/\/doi.org\/10.1016\/S1470-2045(24)00600-4","journal-title":"Lancet Oncol"},{"issue":"12","key":"2541_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2024.101652","volume":"9","author":"SM Silverwood","year":"2024","unstructured":"Silverwood SM, Waeldner K, Demeulenaere SK, Keren S, To J, Chen JJ, Kouzi ZE, Ayoub A, Grover S, Lichter KE, Mohamad O (2024) The Relationship Between Travel Distance for Treatment and Outcomes in Patients Undergoing Radiation Therapy: A Systematic Review. Adv Radiat Oncol 9(12):101652. https:\/\/doi.org\/10.1016\/j.adro.2024.101652","journal-title":"Adv Radiat Oncol"},{"issue":"12","key":"2541_CR17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1007\/s00066-025-02418-8","volume":"201","author":"M Trommer","year":"2025","unstructured":"Trommer M, Gillett P, Franchini F, Trapani K, Hornby C, Abraham S, Herath D, Gough K, Donohoe K, Tran P, Foroudi F, M IJ, Khor R (2025) Travel distance and potential disparities in palliative radiotherapy access for cancer patients in Victoria, Australia. Strahlenther Onkol 201(12):1296\u20131305. https:\/\/doi.org\/10.1007\/s00066-025-02418-8","journal-title":"Strahlenther Onkol"},{"issue":"7-8","key":"2541_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2025.104714","volume":"29","author":"JM Hannoun-Levi","year":"2025","unstructured":"Hannoun-Levi JM, Renard S, Pommier P, Houdou L, Mignot F, Charret J, Blanchard P, Chargari C, Ferre M (2025) Best practice in brachytherapy: 2025 update. Cancer Radiother 29(7-8):104714. https:\/\/doi.org\/10.1016\/j.canrad.2025.104714","journal-title":"Cancer Radiother"},{"issue":"11","key":"2541_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00066-023-02137-y","volume":"199","author":"DF Fleischmann","year":"2023","unstructured":"Fleischmann DF, Buttner M, Oertel M, Waltenberger M, Suss C, Ziegler S, Kasmann L, Jazmati D, Schroder A, Maurer M, Linde P (2023) Current situation in radiation oncology residency-Results of a national survey performed by the working group Young DEGRO of the German Society of Radiation Oncology. Strahlenther Onkol 199(11):961\u2013972. https:\/\/doi.org\/10.1007\/s00066-023-02137-y","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"2541_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa2409408","volume":"392","author":"J Hoeppner","year":"2025","unstructured":"Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, Izbicki JR, Gockel I, Gerdes B, Ghadimi M, Reichert B, Lock JF, Bruns C, Reitsamer E, Schmeding M, Benedix F, Keck T, Folprecht G, Lordick F et\u00a0al (2025) Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer. N\u00a0Engl J Med 392(4):323\u2013335. https:\/\/doi.org\/10.1056\/NEJMoa2409408","journal-title":"N Engl J Med"},{"key":"2541_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejca.2021.04.029","volume":"152","author":"C Garbe","year":"2021","unstructured":"Garbe C, Keim U, Gandini S, Amaral T, Katalinic A, Hollezcek B, Martus P, Flatz L, Leiter U, Whiteman D (2021) Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036. Eur J Cancer 152:18\u201325. https:\/\/doi.org\/10.1016\/j.ejca.2021.04.029","journal-title":"Eur J Cancer"},{"issue":"2","key":"2541_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5114\/jcb.2021.105286","volume":"13","author":"C Scherf","year":"2021","unstructured":"Scherf C, Licher J, Mletzko C, Trommel M, Tselis N, Chatzikonstantinou G, Diefenhardt M, Rodel C, Kohn J, Ramm U (2021) Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a\u00a0dosimetric point of view. J\u00a0Contemp Brachytherapy 13(2):179\u2013187. https:\/\/doi.org\/10.5114\/jcb.2021.105286","journal-title":"J Contemp Brachytherapy"},{"issue":"11","key":"2541_CR23","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/jamainternmed.2013.639","volume":"173","author":"E Linos","year":"2013","unstructured":"Linos E, Parvataneni R, Stuart SE, Boscardin WJ, Landefeld CS, Chren MM (2013) Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med 173(11):1006\u20131012. https:\/\/doi.org\/10.1001\/jamainternmed.2013.639","journal-title":"JAMA Intern Med"},{"key":"2541_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-025-01577-x","author":"M Diefenhardt","year":"2025","unstructured":"Diefenhardt M, Tselis N, Achenbach J, Kleemann J, Zeiner K, Schilling B, Scherf C, Chatzikonstantinou G, Ramm U, Rodel C, Licher J (2025) HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMs. Dermatol Ther (Heidelb). https:\/\/doi.org\/10.1007\/s13555-025-01577-x","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"2541_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1470-2045(25)00658-8","volume":"27","author":"C Tang","year":"2026","unstructured":"Tang C, Sherry AD, Hwang H, Farris DP, Francolini G, Di Cataldo V, Livi L, Tran P, Corn PG, Aparicio A, Simontacchi G, Kiess AP, Wang JH, Fonteyne V, Bultijnck R, Phillips R, Deek MP, Olson R, Harrow S, Ost P et\u00a0al (2026) Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X\u2011MET collaboration. Lancet Oncol 27(2):181\u2013190. https:\/\/doi.org\/10.1016\/S1470-2045(25)00658-8","journal-title":"Lancet Oncol"},{"key":"2541_CR26","unstructured":"Statistische \u00c4mter des Bundes und der L\u00e4ner (2011) Zensus Datenbank. https:\/\/ergebnisse.zensus2022.de\/datenbank\/online. Accessed 15.3.2026"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02541-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02541-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02541-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:19:29Z","timestamp":1793765969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02541-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2541"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02541-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Diefenhardt, D.\u00a0Imhoff, N.\u00a0Tselis, C.\u00a0R\u00f6del and D.\u00a0Martin declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics board of the Goethe University Frankfurt (approval number: 2023-1441). The requirement for individual informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}}]}}